IQVIA reported second-quarter 2026 revenue of $4,368 million and GAAP net income of $256 million, with adjusted diluted earnings per share of $3.15 (up 12.1% year-over-year). Adjusted EBITDA was $994 million, and the company raised its full-year 2026 guidance for revenue, adjusted EBITDA and adjusted diluted EPS. R&D Solutions delivered record net new bookings and Commercial Solutions saw accelerated organic growth and increased AI adoption.

Financial Highlights

  • Revenue: $4,368 million for Q2 2026, up 8.7% year-over-year (8.5% at constant currency).
  • Operating income: $506 million for the three months ended June 30, 2026.
  • GAAP net income: $256 million for Q2 2026; GAAP diluted EPS: $1.53.
  • Adjusted EBITDA: $994 million for Q2 2026, up 9.2% year-over-year.
  • Adjusted diluted earnings per share: $3.15 for Q2 2026, up 12.1% year-over-year.

Business Highlights

  • Segment structure: Company reports results in two segments following a simplified organizational model—Commercial Solutions and Research & Development Solutions.
  • R&D Solutions: Reported record net new bookings of $3.15 billion in Q2 2026 (up 19% year-over-year) and a book-to-bill ratio of 1.22x; contracted backlog was $34.2 billion as of June 30, 2026, with ~ $9.2 billion expected to convert to revenue in the next 12 months.
  • Commercial Solutions: Delivered double-digit growth in patient solutions and commercial engagement services, high-single-digit organic growth in analytics and consulting, and increased adoption of AI solutions driving accelerated organic revenue growth.
  • Cash and liquidity: Operating cash flow for Q2 was $558 million (up 26.0% year-over-year) and free cash flow was $360 million (up 23.3% year-over-year); cash and cash equivalents were $1,909 million as of June 30, 2026.
  • Capital allocation: Repurchased $398 million of common stock in Q2 2026 (first-half repurchases $950 million) and had $2,819 million of repurchase authorization remaining as of June 30, 2026.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.